Buys
Open market- Shares
- Avg price
- Total value
Michael Schmertzler - Director at PTC THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- PTCT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Michael Schmertzler in PTC THERAPEUTICS, INC.
Sells
Open market- Shares
- -25,000
- Avg price
- $72.22
- Total value
- -$1,805,411
Net
Past year- Shares
- -25,000
- Share %
- -100%
- Total value
- -$1,805,411
Reported holdings for Michael Schmertzler in PTC THERAPEUTICS, INC.
Form 4 holding
Director
PTC THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 1,361,594
- Estimated value
- $99,287,434
- Report date
- 20 Aug 2026
- Price
- $72.92
- Ownership
- Indirect
Form 4 holding
Director
PTC THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 163,266
- Estimated value
- $13,317,607
- Report date
- 19 Aug 2026
- Price
- $81.57
- Ownership
- Direct
Form 4 holding
Director
PTC THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 6,950
- Estimated value
- $476,080
- Report date
- 02 Jan 2026
- Price
- $27.05
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael Schmertzler in PTC THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.